Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation

Leukemia. 2024 Apr 17. doi: 10.1038/s41375-024-02251-5. Online ahead of print.
No abstract available